19. Mai 2022 – The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended authorising the use of Vaxzevria as a booster dose for adults who have received Vakzevria or an mRNA Covid-19 vaccine for their initial vaccination. Vaxzevria is a vaccine for preventing Covid-19 in people aged 18 years and older. Vaxzevria is made up of another virus (of the adenovirus family) that has been modified to contain the gene for making a protein from SARS-CoV-2.

For more information, see here.